Skip to main content
Log in

A pharmacological method to estimate the pK I of competitive inhibitors of agonist uptake processes in isolated tissues

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

An equation is derived from a mathematical model (proposed by Furchgott) which, under certain circumstances, estimates the pK I (-log dissociation constant) of a competitive inhibitor of agonist uptake by utilizing the sensitization of isolated tissues, to the substrate-agonist, by uptake inhibition. The method is theoretically more sound and appears to be improved by the use of potency-ratios of the substrate-agonist and an agonist which is not a substrate for the uptake process since this allows for the detection and correction of receptor and toxic effects of uptake inhibitors. The pK I values of cocaine, desmethylimipramine and imipramine for the neuronal uptake of norepinephrine were estimated by this method in guinea-pig tracheae and left atria. Also, the pK I values for 17 β-oestradiol, corticosterone, clonidine and metanephrine for the extraneuronal uptake of isoproterenol were estimated in guinea-pig tracheae (and cat left atria for 17 β-oestradiol). All estimates were consistent with literature pK I values obtained biochemically with radiolabelled substrates.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58

    Google Scholar 

  • Blinks JR (1965) Convenient apparatus for recording contractions of isolated heart muscle. J Appl Physiol 20:755–757

    Google Scholar 

  • Brimijoin S, Pluchino S, Trendelenburg U (1970) On the mechanism of supersensitivity of norepinephrine in the denervated cat spleen. J Pharmacol Exp Ther 175:503–513

    Google Scholar 

  • Burgen ASV, Iversen LL (1965) The inhibition of noradrenaline uptake by sympathetic amines in the rat isolated heart. Br J Pharmacol 25:34–49

    Google Scholar 

  • Drew GM, Hildich A, Levy GP (1978) Effect of labetalol on the uptake of [3H]-(−)-noradrenaline into the isolated vas deferens of the rat. Br J Pharmacol 63:471–474

    Google Scholar 

  • Ebner F, Waud DR (1978) The role of uptake of noradrenaline for its positive inotropic effect in relation to muscle geometry. Naunyn-Schmiedeberg's Arch Pharmacol 303:1–6

    Google Scholar 

  • Foster RW (1967) The potentiation of the responses to noradrenaline and isoprenaline in guinea-pig isolated tracheal chain preparation by desipramine, cocaine, phentolamine, phenoxybenzamine, guanethidine, metanephrine and cooling. Br J Pharmacol 31:466–482

    Google Scholar 

  • Furchgott RF (1972) The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In: Blaschko H, Muscholl E (eds) Handbuch der experimentellen Pharmakologie, vol 33, Catecholamines. Springer, Berlin Heidelberg New York, p 283

    Google Scholar 

  • Green AL (1976) The kinetics of enzyme action and inhibition in intact tissues and tissue slices, with special reference to cholinesterase. J Pharm Pharmacol 28:265–274

    Google Scholar 

  • Guimarães S, Paiva MQ (1977) Differential influence of block of catechol-O-methyl transferase (COMT) activity and of neuronal uptake on α- and β-adrenergic effects. J Pharm Pharmacol 29:502–503

    Google Scholar 

  • Hughes IE (1978) The stability of noradrenaline in physiological saline solutions. J Pharm Pharmacol 30:124–126

    Google Scholar 

  • Iversen LL (1965) Inhibition of noradrenaline uptake by drugs. J Pharm Pharmacol 17:62–64

    Google Scholar 

  • Iversen LL (1973) Neuronal and extraneuronal uptake mechanisms. In: Usdin E, Snyder SH (eds) Frontiers in catecholamine reseach. Proc. 3rd Ints. catecholamine symp. Pergamon Press New York, p 403

    Google Scholar 

  • Kenakin TP (1980a) Errors in the measurement of agonist potency-ratios produced by uptake processes: A general model applied to betaadrenoceptor agonists. Br J Pharmacol 71:407–417

    Google Scholar 

  • Kenakin TP (1980b) On the importance of agonist concentrationgradients within isolated tissues. Increased maximal responses of rat vasa deferentia to 1-norepinephrine after blockade of neuronal uptake. J Pharm Pharmacol 32:833–838

    Google Scholar 

  • Langer SZ, Trendelenburg U (1969) The effect of a saturable uptake mechanism on the slopes of dose-response curves for sympathomimetic amines and on the shifts of dose-response curves produced by a competitive antagonist. J Pharmacol Exp Ther 167:117–142

    Google Scholar 

  • Langer SZ, Rubio MC (1973) Effects of noradrenaline metabolites on the adrenergic receptors. Naunyn-Schmiedeberg's Arch Pharmacol 276:71–88

    Google Scholar 

  • Salt PJ (1972) Inhibition of noradrenaline uptake in the isolated rat heart by steroids, clonidine and methoxylated phenylethylamines. Eur J Pharmacol 20:329–340

    Google Scholar 

  • Trendelenburg U (1963) Supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev 15:225–276

    Google Scholar 

  • Trendelenburg U (1968) The effect of cocaine on the pacemaker of isolated guinea-pig atria. J Pharmacol Exp Ther 161:22–31

    Google Scholar 

  • Trendelenburg U (1972) Factors influencing the concentration of catecholamines at the receptors. In: Blaschko H, Muscholl E (eds) Handbuch der experimentellen Pharmakologie, vol 33, Catecholamines. Springer, Berlin Heidelberg New York, p 726

    Google Scholar 

  • Waud DR (1969) A quantitative model for the effect of a saturable uptake on the slope of the dose-response curve. J Pharmacol Exp Ther 167:140–141

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kenakin, T.P. A pharmacological method to estimate the pK I of competitive inhibitors of agonist uptake processes in isolated tissues. Naunyn-Schmiedeberg's Arch. Pharmacol. 316, 89–95 (1981). https://doi.org/10.1007/BF00505300

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00505300

Key words

Navigation